On July 16, 2020 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that details of its plans to report second quarter 2020 financial results on August 3, 2020 (Press release, Ligand, JUL 16, 2020, View Source [SID1234562041]). Ligand’s CEO John Higgins, President and COO Matt Foehr, and Executive Vice President and CFO Matt Korenberg will host the conference call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Second Quarter 2020 Earnings Conference Call

What:

Ligand conference call to discuss financial results and provide general business updates

Date:

Monday, August 3, 2020

Time:

8:30 a.m. Eastern time (5:30 a.m. Pacific time)

Conference Call:

Dial (833) 325-0071 within the U.S.

Dial (720) 405-1612 outside the U.S.

Conference ID is 1697855

Webcast:

Live conference call webcast and replay accessible at www.ligand.com